BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 1537371)

  • 21. Prevalence of anti-group B streptococcal type III capsular IgG antibodies in the United Kingdom and an analysis of their specific IgG subclasses.
    Feldman RG; Ferrante A
    J Infect Dis; 1990 Oct; 162(4):883-7. PubMed ID: 2205651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody.
    Kim KS; Wass CA; Hong JK; Concepcion NF; Anthony BF
    Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Phase 2, Randomized, Control Trial of Group B Streptococcus (GBS) Type III Capsular Polysaccharide-tetanus Toxoid (GBS III-TT) Vaccine to Prevent Vaginal Colonization With GBS III.
    Hillier SL; Ferrieri P; Edwards MS; Ewell M; Ferris D; Fine P; Carey V; Meyn L; Hoagland D; Kasper DL; Paoletti LC; Hill H; Baker CJ
    Clin Infect Dis; 2019 May; 68(12):2079-2086. PubMed ID: 30281066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of group B streptococcus type III polysaccharide-specific antibody concentrations in human sera is antigen dependent.
    Bhushan R; Anthony BF; Frasch CE
    Infect Immun; 1998 Dec; 66(12):5848-53. PubMed ID: 9826364
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine.
    Vidarsson G; Sigurdardottir ST; Gudnason T; Kjartansson S; Kristinsson KG; Ingolfsdottir G; Jonsson S; Valdimarsson H; Schiffman G; Schneerson R; Jonsdottir I
    Infect Immun; 1998 Jun; 66(6):2866-70. PubMed ID: 9596761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isotype concentrations of human antibodies to group A meningococcal polysaccharide.
    Rautonen N; Pelkonen J; Sipinen S; Käyhty H; Mäkelä O
    J Immunol; 1986 Oct; 137(8):2670-5. PubMed ID: 3093581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines.
    Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Edwards MS; Kasper DL
    J Infect Dis; 2004 Mar; 189(6):1103-12. PubMed ID: 14999615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14.
    Guttormsen HK; Baker CJ; Nahm MH; Paoletti LC; Zughaier SM; Edwards MS; Kasper DL
    Infect Immun; 2002 Apr; 70(4):1724-38. PubMed ID: 11895934
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cervical secretions in pregnant women colonized rectally with group B streptococci have high levels of antibodies to serotype III polysaccharide capsular antigen and protein R.
    Hordnes K; Tynning T; Kvam AI; Bevanger L; Brown TA; Jonsson R; Haneberg B
    Scand J Immunol; 1998 Feb; 47(2):179-88. PubMed ID: 9496695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine.
    Shahid NS; Steinhoff MC; Hoque SS; Begum T; Thompson C; Siber GR
    Lancet; 1995 Nov; 346(8985):1252-7. PubMed ID: 7475716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Quantitation of IgG antibodies to type Ia group B streptococcal type-specific polysaccharides measured by enzyme-linked immunosorbent assay].
    Sugiyama M; Kojima M; Yasuda Y; Hori Y; Nishiyama Y; Sugiyama A; Kido N; Ota M
    Kansenshogaku Zasshi; 1990 Jul; 64(7):840-6. PubMed ID: 2230372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine.
    Paoletti LC; Wessels MR; Michon F; DiFabio J; Jennings HJ; Kasper DL
    Infect Immun; 1992 Oct; 60(10):4009-14. PubMed ID: 1398913
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IgG subclasses compared in maternal and cord serum and breast milk.
    Gasparoni A; Avanzini A; Ravagni Probizer F; Chirico G; Rondini G; Severi F
    Arch Dis Child; 1992 Jan; 67(1 Spec No):41-3. PubMed ID: 1536584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines.
    Brigtsen AK; Kasper DL; Baker CJ; Jennings HJ; Guttormsen HK
    J Infect Dis; 2002 May; 185(9):1277-84. PubMed ID: 12001045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alpha C protein as a carrier for type III capsular polysaccharide and as a protective protein in group B streptococcal vaccines.
    Gravekamp C; Kasper DL; Paoletti LC; Madoff LC
    Infect Immun; 1999 May; 67(5):2491-6. PubMed ID: 10225912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Level of maternal IgG anti-group B streptococcus type III antibody correlated with protection of neonates against early-onset disease caused by this pathogen.
    Lin FY; Weisman LE; Azimi PH; Philips JB; Clark P; Regan J; Rhoads GG; Frasch CE; Gray BM; Troendle J; Brenner RA; Moyer P; Clemens JD
    J Infect Dis; 2004 Sep; 190(5):928-34. PubMed ID: 15295698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to type III group B streptococcal polysaccharide in breast milk.
    Edwards MS; Munoz FM; Baker CJ
    Pediatr Infect Dis J; 2004 Oct; 23(10):961-3. PubMed ID: 15602200
    [TBL] [Abstract][Full Text] [Related]  

  • 38. L-ficolin and capsular polysaccharide-specific IgG in cord serum contribute synergistically to opsonophagocytic killing of serotype III and V group B streptococci.
    Fujieda M; Aoyagi Y; Matsubara K; Takeuchi Y; Fujimaki W; Matsushita M; Bohnsack JF; Takahashi S
    Infect Immun; 2012 Jun; 80(6):2053-60. PubMed ID: 22451515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgG subclasses and antibodies to group B streptococci, pneumococci, and tetanus toxoid in preterm neonates after intravenous infusion of immunoglobulin to the mothers.
    Morell A; Sidiropoulos D; Herrmann U; Christensen KK; Christensen P; Prellner K; Fey H; Skvaril F
    Pediatr Res; 1986 Oct; 20(10):933-6. PubMed ID: 3534781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of IgM antibody to group B Streptococcus type III in human infants.
    Boyer KM; Klegerman ME; Gotoff SP
    J Infect Dis; 1992 Jun; 165(6):1049-55. PubMed ID: 1583322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.